APIs per la ricerca e le impurità

<p>Bezafibrate is a drug product that is used in the treatment of hyperlipidemia. It is an impurity standard for bezafibrate 1-o-β-glucuronide, which can be used as an analytical standard for HPLC analysis. Bezafibrate 1-o-β-glucuronide can also be used to evaluate the metabolism of bezafibrate through animal studies.</p>

<p>Please enquire for more information about Rosuvastatin EP Impurity C sodium including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amine is a chemical compound that is used in various industries. It is commonly used as an intermediate or starting material for the synthesis of other compounds. This compound may contain impurities such as sulfadiazine, glutamate, fatty acids, basic proteins, methanol, acetyltransferase, chemokines, chamomile extract, cellulose, biomass, industrial products, epidermal growth factors, xylose, and growth factors. Please note that this compound is not intended for human consumption and should be handled with care.</p>

<p>Please enquire for more information about 2-Desmethylene-2-chloromethyl ethacrynic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about Desethanol emedastine dihydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>S(-)-BZM is a potent kinase inhibitor that has been shown to induce apoptosis in cancer cells. It is an analog of the natural product staurosporine and has been isolated from human urine. S(-)-BZM inhibits the activity of several kinases, including protein kinase C and cyclin-dependent kinases, which are involved in cell cycle regulation and tumor growth. This drug has been tested on various cancer cell lines, including leukemia, and has demonstrated significant antitumor activity. S(-)-BZM is a promising medicinal agent for the treatment of cancer and other diseases characterized by abnormal cell proliferation.</p>

<p>3',5'-Di-O-p-chlorobenzoyl-2-deoxy-5-azacytosine is a drug product that is an impurity in the synthesis of 5'-azacytosine. The chemical name for 3',5'-Di-O-p-chlorobenzoyl-2-deoxy-5-azacytosine is 3,3'-di(O,O'-dichlorobenzyl)-2,5'-dideoxycytidine. It has a molecular weight of 302.7 g/mol and a melting point of 130°C. This chemical compound has been shown to be metabolized by human liver microsomes to a number of metabolites, including 2-, 3-, and 4-(hydroxymethyl)uracil and 4-(aminomethyl)uracil. 3',5'-Di-O-p-chlorobenzoyl -2 deoxy</p>

<p>Pemetrexed is an antifolate drug that is used to treat cancer. It is a prodrug of pemetrexed disodium, which is converted to pemetrexed in the body by esterases. Pemetrexed is metabolized to its active form, D-pemetrexed, which inhibits DNA synthesis and the growth of cells by inhibiting thymidylate synthase. D-Pemetrexed hydrate is a high purity, pharmacopoeia grade impurity standard for use in research and development or as a custom synthesis. It has been shown to inhibit the growth of certain types of cancer cells and can be used in combination with other treatments such as chemotherapy or radiation therapy.</p>

<p>Chlorthalidone impurity E is an analytical standard for the HPLC analysis of chlorthalidone in pharmaceutical drug products and is a metabolite of chlorthalidone. Chlorthalidone impurity E is an API impurity that can be found in the synthesis of chlorthalidone, and it has been detected as a minor component in certain drug products. It is important to have an accurate specification for this compound, since it can affect the pharmacological properties of the drug product. The purity level of this compound must be at least 98% or greater to ensure that there are no contaminants present. This compound is also a metabolite of chlorthalidone and is used as a pharmacopoeia reference substance for testing equipment calibration.END&gt;</p>

<p>Benquinox is a potent inhibitor of protein kinases that has shown promise in the treatment of cancer. It works by blocking the activity of certain kinases that are involved in cell growth and division, leading to apoptosis (programmed cell death) in cancer cells. Benquinox is an analog of donepezil, a drug used to treat Alzheimer's disease. Studies have shown that Benquinox inhibits tumor growth and induces apoptosis in human cancer cell lines. It has also been found to be effective against urinary tract tumors in Chinese patients. As an anticancer agent, Benquinox is being investigated for its potential use as a targeted therapy for various types of cancer. Its ability to inhibit kinases makes it a promising candidate for combination therapies with other kinase inhibitors.</p>